abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

22 Feb 2002

Author:
UN Wire

HIV/AIDS: South Africa To Boost Drug Research, Not Offer Universal Access

South Africa said today it will expand research on use of Nevirapine to curb mother-to-child HIV transmission instead of providing immediate universal access to the drug as activists and some opposition figures have asked. Boehringer-Ingelheim, the manufacturer, has offered South Africa free Nevirapine for the next five years.